Astellas’s New 3-Year Plan Targets Sales Growth in Mid-Single-Digit Range

May 27, 2015
Astellas Pharma announced its new strategic business plan for FY2015-2017 on May 26. During this period, the company will aim for sales growth in the mid-single-digit range with a higher rate of growth in core operating profit. The plan sets...read more